Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety Study of Using Regulatory T Cells Induce Liver Transplantation Tolerance (Treg)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified December 2014 by Nanjing Medical University.
Recruitment status was:  Active, not recruiting
Sponsor:
Collaborator:
University of Minnesota - Clinical and Translational Science Institute
Information provided by (Responsible Party):
Ling Lu, Nanjing Medical University
ClinicalTrials.gov Identifier:
NCT01624077
First received: January 16, 2012
Last updated: February 21, 2015
Last verified: December 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2015
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)